These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 21420535)

  • 41. Through the lens of implementation science: next steps in understanding the significance of organizational justice.
    Hogan TP
    Med Care; 2012 Oct; 50(10):829-30. PubMed ID: 22982734
    [No Abstract]   [Full Text] [Related]  

  • 42. Integrating diabetes technologies with team-based primary care for type 2 diabetes: A pilot trial.
    O'Brien MJ; Stephen JJ; Norton KL; Meehan TP; Vojta D; Ackermann RT
    Prim Care Diabetes; 2021 Dec; 15(6):1104-1106. PubMed ID: 34301495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anemia in Patients with Type 2 Diabetes Mellitus.
    Barbieri J; Fontela PC; Winkelmann ER; Zimmermann CE; Sandri YP; Mallet EK; Frizzo MN
    Anemia; 2015; 2015():354737. PubMed ID: 26640706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Primary care and rehabilitation: what do health centres think about the relationships between healthcare levels?].
    Escriche Ros R; Morata Crespo AB
    Aten Primaria; 2012 Oct; 44(10):628-9. PubMed ID: 22981132
    [No Abstract]   [Full Text] [Related]  

  • 45. Clustering Inflammatory Markers with Sociodemographic and Clinical Characteristics of Patients with Diabetes Type 2 Can Support Family Physicians' Clinical Reasoning by Reducing Patients' Complexity.
    Bosnic Z; Yildirim P; Babič F; Šahinović I; Wittlinger T; Martinović I; Majnaric LT
    Healthcare (Basel); 2021 Dec; 9(12):. PubMed ID: 34946413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eliminating Missed Opportunities for Patients with Type 2 Diabetes.
    Rajagopalan S; Pronovost P; Neeland IJ
    Trends Endocrinol Metab; 2021 May; 32(5):257-259. PubMed ID: 33653621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Health-related quality of life, a useful and necessary measure also in primary care].
    Failde I
    Semergen; 2020; 46(8):510-511. PubMed ID: 33069569
    [No Abstract]   [Full Text] [Related]  

  • 48. [Introduction. The challenge of managing type 2 diabetes in primary care].
    Javier García-Soidán F; Javier Ampudia-Blasco F
    Aten Primaria; 2010 Sep; 42 Suppl 1(Suppl 1):1. PubMed ID: 21108513
    [No Abstract]   [Full Text] [Related]  

  • 49. Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations.
    Sun G; Kashyap SR
    J Nutr Metab; 2011; 2011():708183. PubMed ID: 21773024
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trends in Mortality From Diabetes in Spain: On the Right Way.
    Cabezas-Agrícola JM
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):421-422. PubMed ID: 28330610
    [No Abstract]   [Full Text] [Related]  

  • 51. Complexity of drug therapy and its implications for quality of diabetes care.
    Zhang JX
    World J Diabetes; 2011 Jul; 2(7):105-7. PubMed ID: 21860694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Multidisciplinary coordination in the approach to type 2 diabetes mellitus].
    Artola Menéndez S; Rovira Loscos A; Ricart W
    Med Clin (Barc); 2010 Sep; 135 Suppl 2():27-32. PubMed ID: 21420535
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.